Pharmacokinetics of cetuximab and tumor uptake of Zr-89-cetuximab as potential predictive biomarkers for benefit of cetuximab in patients with advanced colorectal cancer.

Van Heiden, EJ; Menke, CW; Boon, E; van Es, S; Huisman, MC; van Dongen, GAMS; Vugts, DJ; De Groot, DJ; Herpen, CMLV; De Vries, E; Hoekstra, OS; Verheul, HMW

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):